Ian is an entrepreneurial scientist with international leadership roles spanning big pharma, biotech and academia focused on translational research.
He is founding Director of the Quadram Institute, UK and was the former founding Director of the ithree institute at the University of Technology Sydney (UTS). His current research focus is on infectious diseases and the microbiome, and development of ‘omics technologies that ultimately impact on health and disease. He currently also serves as Non-Executive Director of Genus plc.
A serial entrepreneur with a track record of success, he was the co-founder and CSO of two anti-infectives drug discovery companies: Arrow Therapeutics (sold to AstraZeneca) and Auspherix. His earlier industry career has included leading groups at the Wellcome Laboratories, UK and at Glaxo-Wellcome, with academic positions including being a founding member of the Wolfson Institute for Biomedical Research at University College London (UCL), and positions at Sheffield, Cambridge and Leicester Universities.
Ian has a PhD in Biochemistry from the University of Leicester.